Abstract
Mitochondrial neuro-gastro-intestinal encephalomyopathy (MNGIE) is a rare and unavoidably fatal disease due to mutations in thymidine phosphorylase (TP). Clinically it is characterized by gastrointestinal dysfunction, malnutrition/cachexia and neurological manifestations. MNGIE diagnosis remains a challenge mainly because of the complexity and rarity of the disease. Thus, our purposes were to promote a better knowledge of the disease in Emilia-Romagna region (ERR) by creating an accurate and dedicated network; to establish the minimal prevalence of MNGIE in Italy starting from ERR. Blood TP activity level was used as screening test to direct candidates to complete diagnostic work-up. During the study period of 1 year, only 10/71 units of ERR recruited 14 candidates. Their screening did not show TP activity changes. An Italian patient not resident in ERR was actually proved to have MNGIE. At the end of study in Italy there were nine cases of MNGIE; thus, the Italian prevalence of the disease is ~0.15/1,000,000 as a gross estimation. Our study confirms that MNGIE diagnosis is a difficult process which reflects the rarity of the disease and, as a result, a low level of awareness among specialists and physicians. Having available novel therapeutic options (e.g., allogenic hematopoietic stem cell transplantation and, more recently, liver transplantation) and an easy screening test, an early diagnosis should be sought before tissue damage occurs irreversibly.
References
Nishino I, Spinazzola A, Hirano M (1999) Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283:689–692
Hirano M, Silvestri G, Blake DM et al (1994) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44:721–727
Filosto M, Scarpelli M, Tonin P et al (2011) Pitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathy. J Inherit Metab Dis 34:1199–1203
Halter JP, Michael W, Schupbach M et al (2015) Allogenic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy. Brain 138:2847–2858
Marti R, Spinazzola A, Tadesse S, Nishino I, Nishigaki Y, Hirano M (2004) Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays. Clin Chem 50:120–124
Hoek HW, van Hoeken D (2003) Review of the prevalence and incidence of eating disorders. Int J Eat Disord 34:383–396
Boschetti E, D’Alessandro R, Bianco F et al (2014) Liver as a source for thymidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathy. PLoS One. doi:10.1371/journal.pone.0096692
Rinaldi R, Bologna ITA-MNGIE Group (2015) Orthotopic liver transplantation in a MNGIE patient as a successful measure to correct biochemical imbalance. Neurol Sci 36(Suppl):S17
Acknowledgments
This work has been supported by the Ita-MNGIE Grant (Ricerca Finalizzata, ‘RF-2009’) from the Ministry of Public Health, Italy. R. De G. received support from ‘Fondazione Del Monte di Bologna and Ravenna’.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was approved by the Ethic Committees of all participating centers of the ERR (protocol#31/2013/O/Tess)
All patients gave their informed consent to the inclusion.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
R. D’Alessandro and R. De Giorgio contributed equally to the manuscript.
Rights and permissions
About this article
Cite this article
D’Angelo, R., Rinaldi, R., Carelli, V. et al. ITA-MNGIE: an Italian regional and national survey for mitochondrial neuro-gastro-intestinal encephalomyopathy. Neurol Sci 37, 1149–1151 (2016). https://doi.org/10.1007/s10072-016-2552-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-016-2552-7